HQP Development Committee

BioCanRx’s mission is to build and foster a network that accelerates Canada’s most promising biologically based cancer therapies into clinical trials.

Dedicated to Training the Next Generation

Training highly qualified personnel (HQP) is key to BioCanRx’s mission of moving cancer therapies from lab to clinic. Our programs support HQP across disciplines such as virology, immunology, and health policy and at every career stage, from students to senior researchers.

The HQP Development Committee helps shape these programs by bringing together investigators, staff, industry, charities, and HQP representatives from across the network.

CURRENT COMMITTEE MEMBERS

Chair

Harold Atkins, MD

Chair, HQP Development Committee, BioCanRx Clinician Scientist, The Ottawa Hospital

Members

Raja Ghosh, PhD

Professor, McMaster University

Bruce Seet, PhD

Director of Medical Affairs, Sanofi Pasteur

Linh Nguyen, PhD

Scientific Associate, University Health Network

Carolina Ilkow, PhD

Assistant Professor, University of Ottawa

Risini Weeratna, PhD

Senior Research Officer, National Research Council of Canada

Megan Mahoney, PhD

Director of Scientific Affairs and Training Programs

Jennifer Quizi, PhD

Director of Biotherapeutics Manufacturing Operations, BioCanRx

Julian Lum, PhD

Senior Scientist, BC Cancer; Associate Prof., University of Victoria

Karin Hermans, PhD

Senior Research Associate, Donna Wall Lab (SickKids)

OBSERVER

Sara Esam

Senior Program Manager, College and Networks, Networks of Centres of Excellence (NCE) Secretary, Board of Directors